New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Harrow Health, Inc.
HROW
Shape
US Flag

NASDAQ

Unprofitable

EPS improving

Unprofitable

EPS improving

1B

Drug Manufacturers - Specialty & Generic

Next Earning date - 18 Mar 2025

1B

Drug Manufacturers - Specialty & Generic

Next Earning date - 18 Mar 2025

30.57USD

Shape0.15 ( 0.49%)
moonAfter-hours 30.58$arrow-right-up0.01 (0.03%)
Market Closed (as of Feb 18, 21:00 EDT)
favorite-chart

Relative Strenght

96
favorite-chart

Volume Buzz

-7%
favorite-chart

Earning Acce

Yes
favorite-chart

Dist 52w H.

48%

Quote Panel

Shape
Updated February 18, 2025
1W 2.10 % 1M -15.32 % 3M -23.00 % 1Y 166.06 %

Key Metrics

Shape
  • Market Cap

    1.09B


  • Shares Outstanding

    35.61M


  • Share in Float

    30.74M


  • Dividende

    0


  • Earning Date

    18 Mar 2025


  • Price Target

    30.57


  • Average Volume

    350627


  • Beta

    0.688


  • Range

    9.3-59.23


  • Industry

    Drug Manufacturers - Specialty & Generic


  • Website

    https://www.harrowinc.com


  • Sector

    Healthcare


Fundamentals

Shape

Relative Strength

Shape

HROW

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$281M

Shape471%

2025-Revenue

$0.39

Shape423%

2025-EPS

$105K

Shape-102%

2025-EBITDA

Analyst rating

Strong Sell

Sell

Buy

Neutral

Strong Buy

Shape

Buy

Price Target

0.00(-100.00%)

Number of analyst

0

Last analyst upgrade/downgrade

No Data Available

Earnings GrowthShape

status-upYoY

Current

Estimates

Q4.22

arrow
arrow

+800%

0.07
vs -0.01

Q1.23

arrow
arrow

N/A

-0.03
vs 0.03

Q2.23

arrow
arrow

N/A

-0.02
vs 0.01

Q3.23

arrow
arrow

N/A

-0.09
vs -0.06

Q4.23

arrow
arrow

N/A

-0.27
vs 0.07

Q1.24

arrow
arrow

N/A

-0.28
vs -0.03

Q2.24

arrow
arrow

N/A

-0.13
vs -0.02

Q3.24

arrow
arrow

N/A

-0.12
vs -0.09

Q4.24

arrow
arrow

N/A

-0.01
vs -0.27

Q1.25

arrow
arrow

+107%

0.02
vs -0.28

Sales GrowthShape

status-upYoY

Current

Estimates

Q4.22

arrow
arrow

+1%

20.3M  vs 20.2M

Q1.23

arrow
arrow

+18%

26.1M  vs 22.1M

Q2.23

arrow
arrow

+44%

33.5M  vs 23.3M

Q3.23

arrow
arrow

+50%

34.3M  vs 22.8M

Q4.23

arrow
arrow

+79%

36.4M  vs 20.3M

Q1.24

arrow
arrow

+33%

34.6M  vs 26.1M

Q2.24

arrow
arrow

+46%

48.9M  vs 33.5M

Q3.24

arrow
arrow

+44%

49.3M  vs 34.3M

Q4.24

arrow
arrow

+61%

58.4M  vs 36.4M

Q1.25

arrow
arrow

+76%

61M  vs 34.6M

Return on EquityShape

status-upQoQ

Q4.22

arrow
arrow

+4%

0.04
vs -5.31

Q1.23

arrow
arrow

-31%

-0.31
vs 0.04

Q2.23

arrow
arrow

-19%

-0.19
vs -0.31

Q3.23

arrow
arrow

-6%

-0.06
vs -0.19

Q4.23

arrow
arrow

-13%

-0.13
vs -0.06

Q1.24

arrow
arrow

-23%

-0.23
vs -0.13

Q2.24

arrow
arrow

-11%

-0.11
vs -0.23

Q3.24

arrow
arrow

-7%

-0.07
vs -0.11

Institutionnal OwnershipShape

status-upQoQ

Q1.23

arrow
arrow

119

119
vs 100

19%

Q2.23

arrow
arrow

116

116
vs 119

-3%

Q3.23

arrow
arrow

134

134
vs 116

16%

Q4.23

arrow
arrow

116

116
vs 134

-13%

Q1.24

arrow
arrow

119

119
vs 116

3%

Q2.24

arrow
arrow

116

116
vs 119

-3%

Q3.24

arrow
arrow

172

172
vs 116

48%

Q4.24

arrow
arrow

83

83
vs 172

-52%

Earnings Growth

Latest News

HROW

seekingalpha.com

less than 1 hour ago

HROW

seekingalpha.com

15 hours ago